Home > For Meeting Attendees > Innovation Theater

Innovation Theater Schedule

Grab a bite and get informed at the Innovation Theater. Don’t miss out on participating in a non-CME informative lunch or snack break discussion about the latest clinical information as it relates to a specific disease state. Innovation Theater presentations are independently organized and are not an official part of the Internal Medicine 2014 education program.

Thursday, April 10

Morning Break

Lupus: The Disease, The Diagnosis, the Doctors
Supported by American College of Rheumatology
Innovation Theater 1, Exhibit Hall Booth 473
10:30-11:15 a.m.
Listen and engage as a rheumatologist walks you through a real-life case study of a lupus patient, incorporating background information on the disease, details around diagnosing and steps for referral to—and partnering with—rheumatology.
Marc C. Hochberg, M.D., M.P.H.
Professor of Medicine and Epidemiology and Public Health
Head, Division of Rheumatology & Clinical Immunology
University of Maryland School of Medicine

Optimizing patient experience when starting insulin therapy for T2DM
Supported by Sanofi
Innovation Theater 2, Exhibit Hall Booth 173
10:45-11:15 a.m.
This session focuses on the challenges that physicians face when
initiating insulin therapy in patients with Type II diabetes, ADA
guidelines, patient and physician perceptions about insulin therapy and
Lantus clinical studies are also discussed.
Sumon Agarwala, M.D., FACE
Hunterdon Medical Center, 
Flemington, New Jersey


Lunch

Discussion of a Treatment Option for Major Depressive Disorder
Supported by Takeda Pharmaceuticals, Inc and Lundbeck
Innovation Theater 1, Exhibit Hall Booth 473
1:00-1:45 p.m.
C. Brendan Montano
Director, Metabolic and Neuroscience Research
Connecticut Clinical Research Center
Cromwell, Connecticut

Advances in Sleep Apnea Diagnosis and Therapy: New Options for Your Primary Care Patients
Supported by ResMed
Innovation Theater 2, Exhibit Hall Booth 173
1:00-1:45 p.m.
The clinical evidence is well-documented on how treating obstructive sleep apnea (OSA) improves underlying comorbid conditions and reduces patient mortality. Learn more about the importance of diagnosing and treating OSA, new diagnostic options with home sleep testing (HST) and how new PAP comfort features can improve patient adherence.
Paul Doghramji, MD, FAAFP
Family Physician, Collegeville Family Practice; Medical Director of Health Services, Ursinus College,
Collegeville, PA

Afternoon Break

The Latest Information in Therapy for Asthma, COPD, and Exercise-Induced Bronchospasm
Supported by Teva Respiratory, LLC
Innovation Theater 1, Exhibit Hall Booth 473
3:45-4:30 p.m.
This presentation will highlight the latest information in therapy for patients with asthma, COPD, and exercise-induced bronchospasm (EIB). The under-recognition and under-treatment of EIB in America will be reviewed. The presentation will then explore recent evidence about patients' knowledge and tracking of medication in inhalers with a built-in dose counter.
Dennis K. Ledford, MD
Professor of Medicine and Pediatrics
Mabel and Ellsworth Simmons
Professor of Allergy and lmmunology
University of South Florida College of Medicine
Tampa, Florida

 

Friday, April 11

Morning Break

Advances in Aerosol Therapy for Patients with Asthma or Allergic Rhinitis
Supported by Teva Respiratory, LLC
Innovation Theater 1, Exhibit Hall Booth 473
10:30-11:15 a.m.
This presentation will highlight the latest information for use for patients with asthma and for patients with allergic rhinitis. Recent studies which evaluate small-particle ICS formulations and their ability to target chronic inflammation in both large and small airways in asthma will be discussed. The presentation will also explore the potential benefits of waterless intranasal corticosteroid therapy for allergic rhinitis patients.
Rand A. Malone, IV, MD
Assistant Clinical Professor at Florida State School of Medicine
Southeast Asthma & Allergy Center
Tallahassee, Florida

Lunch

Closing the Gap on Thrombotic Events
Supported by Janssen Pharmaceuticals
Innovation Theater 1, Exhibit Hall Booth 473
1:00-1:45 p.m.
This lecture will discuss treatment options for patients with deep vein thrombosis and pulmonary embolism, and how they can reduce the risk of recurrent thrombotic events. It will also present options for reducing the risk of stroke in patients with nonvalvular atrial fibrillation.
Ronald T. Uszenski, MD

A Novel Treatment Option for Chronic Weight Management
Supported by Eisai Inc.
Innovation Theater 2, Exhibit Hall Booth 173
1:00-1:45 p.m.
This session will present a novel pharmacotherapeutic option for addressing the obesity epidemic. A  physician experienced in chronic weight management will describe the benefits and limitations of  current treatment options, and discuss the mechanism of action, and clinical safety and efficacy data for  a novel pharmacotherapy.
Christopher D. Still, DO, FACN, FACP
Medical Director, Center for Nutrition & Weight Management
Director, Geisinger Obesity Research Institute
Medical Director, Employee Wellness Geisinger Health Care System
Adjunct Assistant Professor of Medicine
Temple University School of Medicine
Danville, Pennsylvania

Afternoon Break

Hepatic Encephalopathy: A Clinical Dialogue on a Chronic Complication of Cirrhosis
Supported by Salix Pharmaceuticals, Inc.
Innovation Theater 1, Exhibit Hall Booth 473
3:45-4:30 p.m.
Hepatic encephalopathy (HE) is a chronic complication of cirrhosis that causes a variety of mental and physical symptoms. HE can occur in up to 45% of patients with cirrhosis. It is a debilitating condition marked by a cycle of remission followed by recurrence that is difficult to break. This program explores a twice-daily therapy for reducing the risk of HE recurrence.
Paul J. Gaglio, MD, FACP, AGAF
Professor Of Clinical Medicine
Medical Director: Adult Liver Transplantation
Division of Hepatology
Montefiore Medical Center and Albert Einstein College of Medicine
Bronx, New York
 

*Innovation Theater presentations are independently organized and are not an official part of the Internal Medicine 2014 education program.